International Society for the Study of Women's Sexual Health

DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

 

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH Annual Meeting 2020
March 5-8, 2020   40 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

ISSWSH Sexual Pain Course 2020
April 17-18, 2020 83 days left
Georgetown University Medical Center, Medical and Dental Building, Washington, DC, USA
Read more...

ISSWSH Fall Course 2020
November 19-21, 2020   299 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2021
March 4-7, 2021   404 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

Registration for the ISSWSH Sexual Pain Course is still open, but hurry, space is limited! https://t.co/4XTF1jxt9T ISSWSH
"Stamping Out Online #SexTrafficking May Have Pushed It Underground" https://t.co/ZW3NKqb7k4" ISSWSH
ISSWSH celebrates alongside all Americans to honor the life of Martin Luther King, Jr. #LetFreedomRing ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!